skip to content

Department of Chemical Engineering and Biotechnology


The Department of Chemical Engineering and Biotechnology has long recognised the need for a greater level of commercialisation of public and charity funded research, as well as for educational programmes focused on instilling the enterprise mindset in future generations. Indeed, the Department already has a strong record in facilitating technology transfer from its research platforms to the marketplace: In the last decade, the Institute of  Biotechnology alone has filed around 100 patent applications, established nine successful spin-off companies and have been awarded the Queen’s Anniversary Prize for its 21st century vision for bio-entrepreneurship.

We believe that the Department of Chemical Engineering and Biotechnology is a most attractive collaborative partner for joint research with industry. However, we also recognise that our impact from fundamental research in processes, healthcare and materials arises via different routes and cultural pathways. Impact is driven through:

  • Industrial links via consultancy, studentships, contracts and longer term research programmes, which can lead to improved processes, thereby enhancing productivity, competitiveness and wealth creation
  • Entrepreneurship, leading to spin-outs, where CEB has extended this to embrace social and ethical entrepreneurship
  • Clinical relationships resulting from a combination of entrepreneurial and collaborative activities


University Enterprise activities:

Latest news

Dr Hirak Patra to join UCL as Associate Professor

3 April 2020

Hirak Patra, a senior researcher in our Biosystems Engineering group, is to become Associate Professor in Nanomedicine and Regenerative Medicine at UCL.

'Green' production of magnetic silica beads wins Twitter poster prize and is our highlighted paper this month

3 April 2020

David Brossault, PhD student in our Colloidal Dispersions Group presented his recent work developing a green method to produce metal doped...

MOF homing capsule targets central powerhouse of cancer cells

2 April 2020

Researchers from our department have shown how metal-organic frameworks could target drug delivery to mitochondria in cancer cells, knocking out their central powerhouses and inducing rapid cell death, while drastically reducing the required drug dose.